SecBot SecBot
8-K ·Filed Jul 6, 2026

OMER

OMEROS CORP
NEUTRAL
Impact 4/10
Horizonweeks Processed4mo ago SEC0001552781-26-000377
8-K context-dependent: Items 8.01
Actionable Insight • Neutral

The note repurchases reduce potential dilution from conversion, a modest positive for equity holders. Watch for announcement of replacement debt financing, which could alter leverage. The second tranche closes by July 30, monitor for any adjustments based on stock price during the averaging period.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$10.34
T+0 close · Jul 6, 2026 · via day close
Latest settled
+86.17%
T+60 · $19.25
Vs SPY
+84.45%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jul 6 $10.34entry
  2. T+1 · 4mo ago −0.10%α +0.38% · $10.33
  3. T+5 · 4mo ago −0.58%α −1.07% · $10.28
  4. T+20 · 4mo ago +14.51%α +15.07% · $11.84
  5. T+60 · 7w ago +86.17%α +84.45% · $19.25
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Omeros disclosed the completion of a $16.0M principal repurchase of its 9.50% Convertible Senior Notes due 2029 for ~$31.3M, and entered new agreements to repurchase up to an additional $14.5M principal for up to ~$31.0M. These transactions reduce convertible debt overhang and potential dilution, but consume significant cash that may be replaced with non-convertible debt.

Key Facts

  • Completed repurchase of $16.0M aggregate principal amount of 9.50% Convertible Senior Notes due 2029 for ~$31.3M total, leaving $54.8M outstanding.
  • Entered new agreements to repurchase up to ~$14.5M additional principal for up to ~$31.0M, expected to close July 20–30, 2026.
  • If fully executed, ~$40.3M aggregate principal of Notes will remain outstanding.
  • Company may replace cash used with unsecured or limited-collateral debt not convertible into equity.

Financial Impact

Total cash outlay of up to ~$62.3M for both tranches, representing ~9.3% of market cap ($672M). Reduces convertible debt from ~$71.3M to ~$40.3M.

debtdilutioncash

Risk Factors

  • Cash depletion of ~$62.3M may pressure liquidity if not replaced with new debt.
  • New non-convertible debt could increase leverage and interest expense.
  • Repurchase premium (~2x principal) reflects significant cost to retire the notes.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
70% bullish (10 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001552781-26-000377
Document: 0001552781-26-000377-index-headers.html0001552781-26-000377
Document: 0001552781-26-000377-index.html0001552781-26-000377
Document: 0001552781-26-000377.txt0001552781-26-000377

Track record

12 reports on OMER

Performance horizon

2 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +98.11% at T+60 after the Jul 20, 2026 report. 3 of 3 went positive at some point.

Filters
  1. Nov 6, 202610d ago Institutional Cluster Neutral 3/10 Entry $16.92 Now $16.68 −1.42% settles Feb 4
  2. Oct 30, 202617d ago 8-K Neutral 3/10 Entry $17.83 Now $16.68 −6.45% settles Jan 29
  3. Sep 1, 202610w ago Insider Cluster Neutral 2/10 Entry $18.86 Now $16.68 −11.56% settles Nov 27
  4. Aug 28, 202611w ago Insider Cluster Neutral Not scored Entry $18.79 Now $16.68 −11.23% settles Nov 24
  5. Aug 25, 202611w ago Insider Cluster Neutral 3/10 Entry $18.22 Now $16.68 −8.45% settles Nov 19
  6. Aug 21, 202612w ago Insider Cluster Neutral 2/10 Entry $19.32 Now $16.68 −13.66% settles Nov 17
  7. Jul 20, 202617w ago 8-K Bullish 5/10 Entry $9.53 to $18.88 Now $16.68 +75.03% ▲ +98.11% +94.14% vs SPY
  8. Jul 6, 202619w ago 8-K Neutral 4/10 Viewing Entry $10.34 to $19.25 Now $16.68 +61.32% ▲ +86.17% +84.45% vs SPY
  9. Jun 18, 202621w ago 8-K Bullish 5/10 Entry $10.28 to $17.46 Now $16.68 +62.26% ▲ +69.84% +67.95% vs SPY
  10. Jun 11, 202622w ago Institutional Cluster Neutral 4/10 Entry $10.18 to $18.95 Now $16.68 +63.85% ▲ +86.15% +81.75% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens in 6h 36m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jul 6, 2026